Amneal Pharmaceuticals (AMRX) Other Operating Expenses (2017 - 2026)

Amneal Pharmaceuticals has reported Other Operating Expenses for 10 years, with the latest figure at -$8.1 million in Q2 2026.

• On a quarterly basis, Other Operating Expenses fell 2176.92% year-over-year to -$8.1 million in Q2 2026; TTM through Jun 2026 was -$1.0 million, a 121.91% decrease from a year earlier, with the FY2025 full-year figure at $5.2 million, up 105.42% from the prior year.
• Other Operating Expenses was -$8.1 million for Q2 2026 at Amneal Pharmaceuticals, down from $6.9 million in the prior quarter.
• The five-year high for Other Operating Expenses was $14.5 million in Q4 2023, with the low at -$251.9 million in Q2 2022.
• Average Other Operating Expenses over 5 years is -$19.1 million, with a median of $59000.0 recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Other Operating Expenses surged 172.15% in 2023, then sank 3740.42% in 2024.
• Over 5 years, Other Operating Expenses stood at -$20.1 million in 2022, then soared by 172.15% to $14.5 million in 2023, then slumped by 112.35% to -$1.8 million in 2024, then surged by 100.06% to $1000.0 in 2025, then sank by 810100.0% to -$8.1 million in 2026.
• The last three Other Operating Expenses figures came in at -$8.1 million (Q2 2026), $6.9 million (Q1 2026), and $1000.0 (Q4 2025), per Business Quant data.